Announced Thu, 23 Jul · 13:17 IST
Solara Active Pharma Q1 FY27: PAT jumps 55% YoY to Rs 16.31 Cr
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-8.1%1-day move
₹537.80
prior close
₹534.95
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1-2.0-1.1-0.0-8.1-6.6————————
Up moveDown movePending
AI summary
Solara Active Pharma posted Q1 FY27 consolidated revenue of Rs 381.60 Cr, up about 20% YoY from Rs 319.15 Cr. PAT rose 55% YoY to Rs 16.31 Cr versus Rs 10.52 Cr, with EPS of Rs 3.52. Includes exceptional gain of Rs 0.86 Cr from gratuity reversal. Company flagged accumulated losses of Rs 286.21 Cr and prepared results on a going concern basis. Demerger of CRAMS and Polymers business into a separate listed entity remains in progress.
Likely market impact
Strong profit growth is positive, but accumulated losses of Rs 286 Cr and explicit going concern note remain key watchpoints. Demerger plan may unlock value.